Exploring the Relationship Between Breast Feeding History and Hormonal, HER2/Neu Receptor Status in Breast Cancer Patients

Authors
DOI:
https://doi.org/10.61706/MECOJ160231
Keywords:
Breastfeeding, Hormonal Receptors, HER2/Neu, Triple-Negative Breast Cancer, Breast cancer Epidemiology
Abstract

It is evident that breastfeeding exerts a significant influence on the risk of developing breast cancer, potentially impacting the biological characteristics of tumors. However, the relationship between this and hormonal and HER2/neu receptor expression remains unclear, particularly in Middle Eastern populations. The objective of this study is to explore the association between breastfeeding history and receptor status (ER, PR, HER2/neu) among breast cancer patients. The present retrospective observational study analysed 144 breast cancer patients. The demographic, reproductive, and tumour-related variables were obtained from the medical records. Patients were categorised based on their breastfeeding history, and receptor patterns were compared using chi-square and Fisher's exact tests. A total of 70.6% of patients had a history of breastfeeding. The present study found an association between breastfeeding and reduced rates of triple-negative breast cancer (TNBC) (p = 0.014). No significant associations were observed between breastfeeding and ER, PR, or HER2/neu expression in isolation. The investigation revealed that demographic variables, including age, parity, and family history of breast cancer, exhibited no statistical correlation with receptor status. The analysis revealed a correlation between breastfeeding history and a reduced incidence of TNBC, suggesting a potential protective effect against more aggressive tumour subtypes. Further studies with larger populations are warranted to validate these findings.

References

Akram, M., Iqbal, M., Daniyal, M., & Khan, A. U. (2017). Awareness and current knowledge of breast cancer. Biological Research, 50(1), 33. https://doi.org/10.1186/s40659-017-0140-9

Angahar, L. T. (2017). An Overview of Breast Cancer Epidemiology, Risk Factors, Pathophysiology, and Cancer Risks Reduction. MOJ Biology and Medicine, 1(4). https://doi.org/10.15406/mojbm.2017.01.00019

Bellanger, M., Zeinomar, N., Tehranifar, P., & Terry, M. B. (2018). Are Global Breast Cancer Incidence and Mortality Patterns Related to Country-Specific Economic Development and Prevention Strategies? Journal of Global Oncology, (4), 1–16. https://doi.org/10.1200/JGO.17.00207

Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394–424. https://doi.org/10.3322/caac.21492

Feng, Y., Spezia, M., Huang, S., Yuan, C., Zeng, Z., Zhang, L., Ji, X., Liu, W., Huang, B., Luo, W., Liu, B., Lei, Y., Du, S., Vuppalapati, A., Luu, H. H., Haydon, R. C., He, T.-C., & Ren, G. (2018). Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes & Diseases, 5(2), 77–106. https://doi.org/10.1016/j.gendis.2018.05.001

Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2019). Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. International Journal of Cancer, 144(8), 1941–1953. https://doi.org/10.1002/ijc.31937

Ferlay, J., Colombet, M., Soerjomataram, I., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2021). Cancer statistics for the year 2020: An overview. International Journal of Cancer, 149(4), 778–789. https://doi.org/10.1002/ijc.33588

Hanahan, D. (2022). Hallmarks of Cancer: New Dimensions. Cancer Discovery, 12(1), 31–46. https://doi.org/10.1158/2159-8290.CD-21-1059

Harbeck, N., Penault-Llorca, F., Cortes, J., Gnant, M., Houssami, N., Poortmans, P., Ruddy, K., Tsang, J., & Cardoso, F. (2019). Breast cancer. Nature Reviews Disease Primers, 5(1), 66. https://doi.org/10.1038/s41572-019-0111-2

Kamińska, M., Ciszewski, T., Łopacka-Szatan, K., Miotła, P., & Starosławska, E. (2015). Breast cancer risk factors. Menopausal Review, 3, 196–202. https://doi.org/10.5114/pm.2015.54346

Kolak, A., Kamińska, M., Sygit, K., Budny, A., Surdyka, D., Kukiełka-Budny, B., & Burdan, F. (2017). Primary and secondary prevention of breast cancer. Annals of Agricultural and Environmental Medicine, 24(4), 549–553. https://doi.org/10.26444/aaem/75943

Kotsopoulos, J. (2018). BRCA Mutations and Breast Cancer Prevention. Cancers, 10(12), 524. https://doi.org/10.3390/cancers10120524

Lukong, K. E. (2017). Understanding breast cancer – The long and winding road. BBA Clinical, 7, 64–77. https://doi.org/10.1016/j.bbacli.2017.01.001

Melvin, J. C., Wulaningsih, W., Hana, Z., Purushotham, A. D., Pinder, S. E., Fentiman, I., Gillett, C., Mera, A., Holmberg, L., & Van Hemelrijck, M. (2016). Family history of breast cancer and its association with disease severity and mortality. Cancer Medicine, 5(5), 942–949. https://doi.org/10.1002/cam4.648

Nascimento, R. G. do. (2022). Epidemiology and risk factors for breast cancer: a literature review. Revista Científica Multidisciplinar Núcleo Do Conhecimento, 05–17. https://doi.org/10.32749/nucleodoconhecimento.com.br/health/risk-factors

Shiovitz, S., & Korde, L. A. (2015). Genetics of breast cancer: a topic in evolution. Annals of Oncology, 26(7), 1291–1299. https://doi.org/10.1093/annonc/mdv022

Skibinski, A., & Kuperwasser, C. (2015). The origin of breast tumor heterogeneity. Oncogene, 34(42), 5309–5316. https://doi.org/10.1038/onc.2014.475

Torre, L. A., Islami, F., Siegel, R. L., Ward, E. M., & Jemal, A. (2017). Global Cancer in Women: Burden and Trends. Cancer Epidemiology, Biomarkers & Prevention, 26(4), 444–457. https://doi.org/10.1158/1055-9965.EPI-16-0858

Tuasha, N., & Petros, B. (2020). Heterogeneity of Tumors in Breast Cancer: Implications and Prospects for Prognosis and Therapeutics. Scientifica, 2020, 1–11. https://doi.org/10.1155/2020/4736091

Zhao, B., Zhao, H., & Zhao, J. (2018). Impact of hormone receptor status on the efficacy of HER2-targeted treatment. Endocrine-Related Cancer, 25(6), 687–697. https://doi.org/10.1530/ERC-18-0029

Cover Image
Downloads
Published
2026-07-21
Data Availability Statement

The data that supports the findings of this study are available from the corresponding author upon reasonable request.

Issue
Vol. 2 No. 3 (2026): July - September
Section
Research Article/Original Research
Categories
License

Copyright (c) 2026 Karrar Kareem Hammood, Muataz Fawzi Hussein

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

Hammood, K. K., & Hussein, M. F. (2026). Exploring the Relationship Between Breast Feeding History and Hormonal, HER2/Neu Receptor Status in Breast Cancer Patients. Middle Eastern Cancer and Oncology Journal, 2(3), 10-16. https://doi.org/10.61706/MECOJ160231

Similar Articles

31-32 of 32

You may also start an advanced similarity search for this article.